APLLTD2026-10-20APLLTD2026-10-202026-10-20iso4217:INRxbrli:pure

533573

Alembic Pharmaceuticals Limited

APLLTD

NOTLISTED

INE901L01018

New

Acquisition of “to be incorporated companies”

false

2026-10-19

12:44:00

2026-10-20

Alembic Global Holding SA

Subsidiary

Alvesta Pharmaceuticals FZCO

Pharmaceuticals

To explore new business opportunities and to promote, sale and distribute pharmaceuticals product(s) of the Company.

Cash

2600000

AED 100,000 (Arab Emirates Dirham One Lakh Only) divided into 100 shares of AED 1,000 each.

Cost/Price

AED 100,000 (Arab Emirates Dirham One Lakh Only) divided into 100 shares of AED 1,000 each.

2026-09-01

United Arab Emirates

Alembic Global Holding SA, a Wholly Owned Subsidiary (‘WOS’) of the Company, has incorporated its WOS named Alvesta Pharmaceuticals FZCO in Dubai, United Arab Emirates, on 1st September, 2026. The intimation regarding the incorporation of the said WOS was received by the Company on 19th October, 2026.